Roivant Sciences Ltd
F:87S

Watchlist Manager
Roivant Sciences Ltd Logo
Roivant Sciences Ltd
F:87S
Watchlist
Price: 18.285 EUR 0.72%
Market Cap: 13.5B EUR

Wall Street
Price Targets

87S Price Targets Summary
Roivant Sciences Ltd

Wall Street analysts forecast 87S stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for 87S is 20.538 EUR with a low forecast of 16.757 EUR and a high forecast of 25.26 EUR.

Lowest
Price Target
16.757 EUR
8% Downside
Average
Price Target
20.538 EUR
12% Upside
Highest
Price Target
25.26 EUR
38% Upside
Roivant Sciences Ltd Competitors:
Price Targets
CMPX
Compass Therapeutics Inc.
144% Upside
AMGN
Amgen Inc
0% Upside
688177
Bio-Thera Solutions Ltd
56% Upside
KMDA
Kamada Ltd
87% Upside
688520
Sinocelltech Group Ltd
26% Upside
096530
Seegene Inc
75% Upside
RIGL
Rigel Pharmaceuticals Inc
4% Upside
LTRN
Lantern Pharma Inc.
511% Upside

Revenue
Forecast

Revenue Estimate
Roivant Sciences Ltd

For the last 4 years the compound annual growth rate for Roivant Sciences Ltd's revenue is 5%. The projected CAGR for the next 3 years is 205%.

5%
Past Growth
205%
Estimated Growth
Estimates Accuracy
-39%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Roivant Sciences Ltd

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
7%
Average Beat

Net Income
Forecast

Net Income Estimate
Roivant Sciences Ltd

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-14%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is 87S's stock price target?
Price Target
20.538 EUR

According to Wall Street analysts, the average 1-year price target for 87S is 20.538 EUR with a low forecast of 16.757 EUR and a high forecast of 25.26 EUR.

What is Roivant Sciences Ltd's Revenue forecast?
Projected CAGR
205%

For the last 4 years the compound annual growth rate for Roivant Sciences Ltd's revenue is 5%. The projected CAGR for the next 3 years is 205%.

Back to Top